Effect of Therapeutic INR on Activated Clotting Times, Heparin Dosage, and Bleeding Risk During Ablation of Atrial Fibrillation
SANDEEP GAUTAM, ROY M. JOHN, WILLIAM G. STEVENSON, RAHUL JAIN, LAURENCE M. EPSTEIN, USHA TEDROW, BRUCE A. KOPLAN, SETH McCLENNEN, GREGORY F. MICHAUDVolume:
22
Year:
2011
Language:
english
Pages:
7
DOI:
10.1111/j.1540-8167.2010.01894.x
File:
PDF, 310 KB
english, 2011